Elizabeth Mily
Vermogen: 675 225 $ op 31-05-2026
Vermogen: 675 225 $ op 31-05-2026
Elizabeth Mily is Executive VP-Strategy & Business Development bij Bristol Myers Squibb Co. In het verleden bekleedde mevrouw Mily de functie van Head-Corporate Strategy & Development bij Thermo Fisher Scientific, Inc., Managing Director bij Goldman Sachs & Co. LLC en Senior Member-Global Healthcare Group bij Barclays US LLC. Zij is afgestudeerd aan de Georgetown University en heeft een bachelordiploma van The Ohio State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
0,01% | 15-05-2026 | 9.009 ( 0,01% ) | 675 225 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
JDRF T1D Fund LLC
JDRF T1D Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Algemeen Directeur | 08-01-2024 |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements. | Algemeen Directeur | 01-06-2026 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01-01-2024 |
| BARCLAYS PLC | Corporate Officer/Principal | 01-01-2020 |
| C.R. BARD | President | 01-01-2017 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 01-01-2010 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 14 |
|---|---|
C. R. Bard, Inc. (New Jersey)
C. R. Bard, Inc. (New Jersey) Medical SpecialtiesHealth Technology Designs, manufactures, packages, distributes and sells medical, surgical, diagnostic & patient care devices | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
The Goldman Sachs Group, Inc.
The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
MyoKardia, Inc.
MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Barclays PLC
Barclays PLC Investment Banks/BrokersFinance Operates as a bank holding company whose subsidiaries engages in retail banking, credit cards, corporate and investment banking and wealth management services | Finance |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Barclays US LLC
Barclays US LLC Regional BanksFinance Operates as a bank holding company whose subsidiaries provides banking services | Finance |
JDRF T1D Fund LLC
JDRF T1D Fund LLC Investment ManagersFinance Acts as Venture Capital Fund | Finance |
JDRF T1D Fund
JDRF T1D Fund Investment ManagersFinance T1D Fund invests in companies located across the globe. The firm focuses on health technology sector. It participates in early stage capital requirements. | Finance |
Stephen Gaynor School
Stephen Gaynor School Miscellaneous Commercial ServicesCommercial Services Operates as a non-profit pre-K school | Commercial Services |
Ampersand Biomedicines
Ampersand Biomedicines BiotechnologyHealth Technology Engages in creating and programming therapeutics & drug development | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau